Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXA9ES
|
||||
Drug Name |
7-[(1E)-1-(ethoxyimino)-2-methylpropyl]-19-methyl-3,13,19,20-tetraazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,21}]tricosa-1(16),2(10),4,6,8,11(15),17,20-octaen-14-one
|
||||
Synonyms |
CHEMBL257794
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H27N5O2
|
||||
Canonical SMILES |
CCO\\N=C(/C(C)C)\\c1ccc2[nH]c3c4CCc5nn(C)cc5c4c6C(=O)NCc6c3c2c1
|
||||
InChI |
InChI=1S/C26H27N5O2/c1-5-33-30-24(13(2)3)14-6-8-19-16(10-14)22-17-11-27-26(32)23(17)21-15(25(22)28-19)7-9-20-18(21)12-31(4)29-20/h6,8,10,12-13,28H,5,7,9,11H2,1-4H3,(H,27,32)/b30-24+
|
||||
InChIKey |
YJQJSZIDTDMDQM-BGABXYSRSA-N
|
||||
Target and Pathway | |||||
Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
Angiopoietin 1 receptor | Target Info | [1587926] | |||
NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
VEGF signaling pathwayP00005:Angiogenesis | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
Beta3 integrin cell surface interactions | |||||
Signaling events mediated by TCPTP | |||||
SHP2 signaling | |||||
S1P1 pathway | |||||
VEGF and VEGFR signaling network | |||||
Integrins in angiogenesis | |||||
Signaling events mediated by VEGFR1 and VEGFR2 | |||||
Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.